InvestorsHub Logo
Followers 138
Posts 22981
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Saturday, 03/23/2024 7:11:02 PM

Saturday, March 23, 2024 7:11:02 PM

Post# of 459967
Alzheimer’s ‘breakthrough’ stalls: why a much-hyped drug is facing approval delays

https://www.theguardian.com/society/2024/mar/24/alzheimers-breakthrough-drugs-medicine-donanemab-aducanumab-lecanemab


Anavex's blarcamesine is an oral "pill" NOT a "mab" monoclonal anti-body.

Good luck and GOD bless,
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News